Replies to post #1061 on Harvard Apparatus Regenerative Tech Inc. (HRGN)

[hondobud]

7th Annual Partnering Forum:

the Cell & Gene Meeting on the Mesa includes a pipeline loaded with partnering opportunities. Collectively, the initial slate of 65+ presenting companies are conducting 170+ clinical trials and have 250+ unique products in the pipeline with an extensive range of possible therapeutic applications.

There has to be more uses for this tech.